Effects of Takrisodokyeum Water Extracts on LNCaP Prostate Cancer Cells
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Androgen receptors (AR) play a crucial role in the development and progression of prostate cancer. Many studies have suggested that prostate cancer cell proliferation is inhibited by AR downregulation, and it has been reported that Takrisodokyeum (TRSDY) induced apoptotic cell death and suppressed tumorigenesis in human leukemia cells. Therefore, this study was conducted to elucidate the mechanism by which TRSDY affects cell growth and AR expression in androgen-dependent prostate cancer cells (LNCaP cells). We investigated the proliferation and apoptosis of LNCaP cells using MTT and DNA fragmentation assays. In addition, we used western blot analysis to assess the effects of TRSDY on the expression of the AR target gene, prostate-specific antigen (PSA). Furthermore, the mechanism of AR downregulation by TRSDY was investigated using EMSA to analyze the binding activity of AR to androgen response elements (ARE). TRSDY significantly suppressed proliferation and induced apoptosis in LNCaP cells. In addition, TRSDY-induced apoptotic cell death was accompanied by activation of caspase-3 and cleavage of its substrate, poly(ADP-ribose) polymerase. TRSDY also inhibited the constitutively expressed- or 5a-dihydrotestosterone (DHT)-induced AR/PSA protein levels. However, these effects were mediated by inhibition of the binding of AR to ARE. TRSDY-mediated AR/PSA downregulation contributes to the inhibition of cell proliferation and the induction of apoptosis in LNCaP human prostate cancer cells. Our findings suggest that TRSDY may be used as a chemopreventive or chemotherapeutic agent for the treatment of prostate cancer.
Abstract
Androgen receptors (AR) play a crucial role in the development and progression of prostate cancer. Many studies have suggested that prostate cancer cell proliferation is inhibited by AR downregulation, and it has been reported that Takrisodokyeum (TRSDY) induced apoptotic cell death and suppressed tumorigenesis in human leukemia cells. Therefore, this study was conducted to elucidate the mechanism by which TRSDY affects cell growth and AR expression in androgen-dependent prostate cancer cells (LNCaP cells). We investigated the proliferation and apoptosis of LNCaP cells using MTT and DNA fragmentation assays. In addition, we used western blot analysis to assess the effects of TRSDY on the expression of the AR target gene, prostate-specific antigen (PSA). Furthermore, the mechanism of AR downregulation by TRSDY was investigated using EMSA to analyze the binding activity of AR to androgen response elements (ARE). TRSDY significantly suppressed proliferation and induced apoptosis in LNCaP cells. In addition, TRSDY-induced apoptotic cell death was accompanied by activation of caspase-3 and cleavage of its substrate, poly(ADP-ribose) polymerase. TRSDY also inhibited the constitutively expressed- or 5a-dihydrotestosterone (DHT)-induced AR/PSA protein levels. However, these effects were mediated by inhibition of the binding of AR to ARE. TRSDY-mediated AR/PSA downregulation contributes to the inhibition of cell proliferation and the induction of apoptosis in LNCaP human prostate cancer cells. Our findings suggest that TRSDY may be used as a chemopreventive or chemotherapeutic agent for the treatment of prostate cancer.
참고문헌 (34)
- Coffey, D.S, "Control of prostate growth", Urology, 17(3), pp.17~24 (1981)
- Voigt, K.D, "Intratissular androgens in benign prostatic hyperplasia and prostatic cancer", J. Steroid. Biochem, 25(5B), pp.749~757 (1986)
- Brewster, S.F, "Gene therapy in urological oncology: principles, strategies and potential", Eur. Urol, 25(3), pp.177~182 (1994)
- Taplin, M.E, "Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer", N. Engl. J. Med, 332(21), pp.1393~1398 (1995)
- Gittes, R.F, "Carcinoma of the prostate", N. Engl. J. Med, 324(4), pp.236~245 (1991)
- Hobisch, A, "Androgen receptor status of lymph node metastases from prostate cancer", Prostate, 28(2), pp.129~135 (1996)
- Jenster, G, "The role of the androgen receptor in the development and progression of prostate cancer", Semin. Oncol, 26(4), pp.407~421 (1999)
- Edwards, J, "Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer", Br. J. Cancer, 89(3), pp.552~556 (2003)
- Balk, S.P, "Androgen receptor as a target in androgen-independent prostate cancer", Urology, 60(3), pp.132~138 (2002)
- Chen, C.D, "Molecular determinants of resistance to antiandrogen therapy", Nat. Med, 10(1), pp.33~39 (2004)
- Santos, A.F, "The androgen receptor: a potential target for therapy of prostate cancer", Steroids, 69(2), pp.79~85 (2004)
- Taplin, M.E, "Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence", J. Cell. Biochem, 91(3), pp.483~490 (2004)
- Oh, W.K, "Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer", J. Clin. Oncol, 22(18), pp.3705~3712 (2004)
- Walsh, P.C, "Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer", J. Urol, 173(6), pp.1966~1967 (2005)
- Pfeifer, B.L, "PC-SPES, a dietary supplement for the treatment of hormone-refractory prostate cancer", BJU Int, 85(4), pp.481~485 (2000)
- Small, E.J, "Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancer", J. Clin. Oncol, 8(21), pp.3595~3603 (2000)
- Kwon, K.B, "Induction of apoptosis by takrisodokyeum through generation of hydrogen peroxide and activation of caspase-3 in HL-60 cells", Life Sci., 73(15), pp.1895~1906 (2003)
- Yang, K.H, "Study on Effect of Takrisodokyeum Extract on Antitumoral Activity and Immune Response", The Korean Journal of Oriental Medical Prescription, 5, pp.147~168 (1997)
- Mosmann, T, "Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays", J. Immunol. Methods, 65(1), pp.55~63 (1983)
- Ikezoe, T, "PC-SPES: Molecular mechanism to induce apoptosis and down-regulate expression of PSA in LNCaP human prostate cancer cells", Int. J. Oncol, 23(5), pp.1461~1470 (2003)
- Nicholson, D.W, "Caspases: killer proteases", Trends Biochem. Sci, 22(8), pp.299~306 (1997)
- Kwon, K.B, "Chemotherapy through mitochondrial apoptosis using nutritional supplements and herbs: a brief overview", J. Bioenerg. Biomembr, 39(1), pp.31~34 (2007)
- Fisher, D.E, "Pathways of apoptosis and the modulation of cell death in cancer", Hematol. Oncol. Clin. North Am, 15(5), pp.931~956 (2001)
- Kanduc, D, "Cell death: apoptosis versus necrosis (review)", Int. J. Oncol (2002), 165-170
- Pang, S, "Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen", Cancer Res, 57(3), pp.495~499 (1997)
- Mikolajczyk, S.D, "A truncated precursor form of prostate-specific antigen is a more specific serum marker of prostate cancer", Cancer Res, 61(18), pp.6958~6963 (2001)
- Yang, Y, "The distribution of PSA, cathepsin-D, and pS2 in BPH and cancer of the prostate", Prostate, 21(3), pp.201~208 (1992)
- Wang, L.G, "Down-regulation of prostate-specific antigen expression by finasteride through inhibition of complex formation between androgen receptor and steroid receptor-binditorconsensus in the prom L.r of the PSA gene in LNCaP cells", Cancer Res, 57(4), pp.714~719 (1997)
- Nakamura, K, "Curcumin down-regulates AR gene expression and activation in prostate cancer cell lines", Int. J. Oncol, 21(4), pp.825~830 (2002)
- Ren, F, "Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells", Oncogene, 19(15), pp.1924~1932 (2000)
- Xing, N, "Quercetin inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells", Carcinogenesis, 22(3), pp.409~414 (2001)
- Huang, W, "Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer", J. Biol. Chem, 274(36), pp.25756~25768 (1999)
- Hsieh, T.C, "Effects of PC-SPES on proliferation and expression of AR", PSA in androgen-responsive LNCaP cells are independent of estradiol, 2002, pp.22(4), 2051~2060
- Hsieh, T.C, "Effects of herbal preparation Equiguard on hormone-responsive and hormone-refractory prostate carcinoma cells: mechanistic studies", Int. J. Oncol, 20(4), pp.681~689 (2002)